EV/EBITDA
-12.54
-0.46-3.81%
95 min ago
Summary
- As of March 10, 2025, AKRO EV/EBITDA is -12.54, with a fall of -0.46 (-3.81%) during the most recent trading day.
- Over the past year, AKRO EV/EBITDA has increased by +0.58 (+4.42%).
- AKRO EV/EBITDA is now -971.79% below its all-time high of -1.17.
Performance
AKRO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AKRO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -3.8% | +3.8% | +3.5% |
| 1 m1 month | +16.7% | -16.7% | -19.1% |
| 3 m3 months | -57.1% | +66.9% | +39.6% |
| 6 m6 months | -65.9% | +105.1% | +66.2% |
| ytdytd | -85.8% | +86.0% | +57.0% |
| 1 y1 year | +4.4% | +59.2% | +36.8% |
| 5 y5 years | -1.6% | +450.9% | +94.9% |
AKRO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.8% | -15.61 | +19.7% | |
| 3 m | 3-month | -5.17 | -142.6% | -16.29 | +23.0% |
| 6 m | 6-month | -5.17 | -142.6% | -16.29 | +23.0% |
| 1 y | 1-year | -3.86 | -224.9% | -16.29 | +23.0% |
| 3 y | 3-year | -1.17 | -971.8% | -26.86 | +53.3% |
| 5 y | 5-year | -1.17 | -971.8% | -26.86 | +53.3% |
| alltime | all time | -1.17 | -971.8% | -38.76 | +67.7% |
Akero Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -12.54(+85.8%) |
| 2024 | -6.75(-8.7%) |
| 2023 | -7.39(-64.7%) |
| Date | Value |
|---|---|
| 2022 | -20.92(+257.6%) |
| 2021 | -5.85(-34.0%) |
| 2020 | -8.87(-28.9%) |
| 2019 | -12.47 |
FAQ
- What is Akero Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Akero Therapeutics?
- What is AKRO EV/EBITDA year-to-date change?
- What is Akero Therapeutics EV/EBITDA year-on-year change?
What is Akero Therapeutics EV/EBITDA?
The current EV/EBITDA of AKRO is -12.54
What is the all time high EV/EBITDA for Akero Therapeutics?
Akero Therapeutics all-time high EV/EBITDA is -1.17
What is AKRO EV/EBITDA year-to-date change?
Akero Therapeutics EV/EBITDA has changed by -5.79 (-85.78%) since the beginning of the year
What is Akero Therapeutics EV/EBITDA year-on-year change?
Over the past year, AKRO EV/EBITDA has changed by +0.58 (+4.42%)